Thalassemia Market size was valued at US$ 3.49 Bn. in 2022 and the total revenue is expected to grow at 9.8% through 2022 to 2029, reaching nearly US$ 6.72 Bn.
Thalassemia Market Overview
Maximize Market Research’s new report on the Global Thalassemia Market 2023-2029 is a valuable resource for understanding the market’s competitors and gaining key business insights. The report provides a comprehensive overview of the market, including its value chain structure, geographical analysis, applications, market size, and forecast (2023-2029). This information can be used to make more informed decisions about the current and future state of the global Thalassemia market.
For detail insights on this market, request for methodology here
@ https://www.maximizemarketresearch.com/request-sample/126529
Thalassemia Market Scope
The report focuses on the key factors that are driving and restraining the growth of the Thalassemia market, as well as the competitive landscape and future prospects. It provides insights into the current and future market trends, demand chain, supply chain, and sales, as well as recent changes in the market.
The report also includes company profiles of the key players in the Thalassemia market, including their overview, financial performance, product portfolio, and strategies. It also uses SWOT and PESTLE analysis to provide a comprehensive view of the market.
Thalassemia Market Segmentation
Currently, thalassemia is not cured; instead, treatment is focused on its symptoms. The most popular therapies for the condition include iron overload from blood transfusions, vitamin supplements, fetal hemoglobin-raising drugs, and indicaxanthin, an antioxidant that stops hemoglobin degradation. In the event that drugs now undergoing phase II/III trials are approved by regulators, there could be a significant market for thalassemia therapies. The introduction of new treatment modalities and rising consumer awareness of current modalities are driving the market in developed regions like North America and Europe. Furthermore, because of their large young populations, developing nations like Pakistan and India are projected to see an increase in demand for thalassemia drugs and therapies in the coming years.
Gene therapy, along with other emerging curative treatments, is expected to be a tremendous success with many genomic products in late-stage testing. There are presently 15 pipeline medications undergoing clinical trials for the treatment of thalassemia. Most of these products are intended to treat the illness and are based on gene therapy. Furthermore, the top-line main and secondary endpoint results from the clinical trials of these drugs were favorable. Notwithstanding significant barriers to clinical development and regulatory ambiguity, gene therapy holds promise for revolutionizing the treatment of thalassemia.
1 Global Thalassemia Market, by Therapeutic Class (2022-2029)
• Iron Chelating Drugs
o Exjade/Jadenu (deferasirox)
• Blood Transfusions
• Folic Acid Supplements
• Others
2 Global Thalassemia Market, by Pipeline (2022-2029)
• Gene Therapy
o LentiGlobin
For any Queries Linked with the Report, Ask an Analyst
@ https://www.maximizemarketresearch.com/request-sample/126529
Thalassemia Market Key Players
1. bluebird bio, Inc.
2. Acceleron Pharma, Inc.
3. Celgene Corporation
4. GlaxoSmithKline plc
5. Incyte Corporation
6. Gamida Cell
7. Kiadis Pharma
8. La Jolla Pharmaceutical Company
9. IONIS Pharmaceuticals
10. Acceleron Pharma
11. Novartis AG
12. Pharmaceuticals Inc
13. Alnylam Pharmaceuticals Inc
14. Calimmune Inc
15. CRISPR Therapeutics
16. Editas Medicine Inc
17. Errant Gene Therapeutics LLC
18. Gamida Cell Ltd
19. Gilead Sciences Inc
20. Incyte Corp
21. Ionis Pharmaceuticals Inc
For any Queries Linked with the Report, Ask an Analyst
@ https://www.maximizemarketresearch.com/market-report/thalassemia-market/126529/
Thalassemia Market Regional Analysis
The global Thalassemia Market’s growth trend is examined in depth throughout the report. It divides the major 5 regions, such as North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, which have global dominance in the Thalassemia market.
Key Questions answered in the Thalassemia Market Report are:
Key offerings:
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
Overview and Scope A network switch refers to hardware that relays data from networks to…
Overview and Scope Phytosterols refer to bioactive substances that naturally occur in plants and have…
Overview and Scope Storage and warehouse leasing refers to renting or leasing storage and warehouse…
Overview and Scope A patient-centric healthcare app refers to a mobile application designed to prioritize…
Overview and Scope Sterile compounding pharmacies are specialized pharmacies that prepare customized medications in a…
Overview and Scope Oil and gas sensors are devices or instruments used in the oil…